9 research outputs found

    Gender and Stress Related Effects on Cardiovascular Health Outcomes

    Get PDF
    Title[j1] : Gender and stress related effects on cardiovascular health outcomes Authors: Michael Cedeño – Master’s, (Tarleton State University), Jennifer Blevins-McNaughton (Tarleton State University) Background and Purpose: To date, only a few investigators have compared the effect that stress may have on health and metabolic outcomes in college age adults. The purpose of this study was to determine the extent to which gender may play a role in self-reported stress and cardiovascular and metabolic outcomes in college age students. Methods: Thirty-eight (N = 38) adults ages 18 to 28 participated in this study. Height, weight, supine resting heart rate and supine blood pressure were measured. Subjects completed the Institute of HeartMath® Stress and Well-Being Survey™ to measure psychological stressors, total stress score, total well-being, and emotional vitality. Total blood cholesterol, HDL, LDL, triglycerides, TC/HDL ratio, and glucose were measured in a randomly selected subset of 13 subjects (N = 13; 7 females and 6 males) using the Cholestech LDX®. Independent t-test and Pearson correlations were used to analyze differences between male and female responses. Results: Males reported significantly higher systolic (P \u3c 0.05) and diastolic (P \u3c 0.05) blood pressures than females as well as glucose levels (P \u3c 0.01). Males also reported higher amounts of work related stress (P \u3c 0.01). Conclusion: This preliminary investigation revealed that college age males reported significantly higher systolic and diastolic blood pressures as well as glucose levels than their female counterparts. Females had significantly higher HDL than males, but this is common in college age adults. There were no significant differences regarding stress components, cardiovascular or metabolic health outcomes and gender. Stress components such as work and finances were shown to correlate with systolic and diastolic blood pressure in both genders, but a larger sample size is needed to find a relationship. [j1

    Assessment of Angiogenesis and Cell Survivability of an Inkjet Bioprinted Biological Implant in an Animal Model

    No full text
    The rapidly growing field of tissue engineering hopes to soon address the shortage of transplantable tissues, allowing for precise control and fabrication that could be made for each specific patient. The protocols currently in place to print large-scale tissues have yet to address the main challenge of nutritional deficiencies in the central areas of the engineered tissue, causing necrosis deep within and rendering it ineffective. Bioprinted microvasculature has been proposed to encourage angiogenesis and facilitate the mobility of oxygen and nutrients throughout the engineered tissue. An implant made via an inkjet printing process containing human microvascular endothelial cells was placed in both B17-SCID and NSG-SGM3 animal models to determine the rate of angiogenesis and degree of cell survival. The implantable tissues were made using a combination of alginate and gelatin type B; all implants were printed via previously published procedures using a modified HP inkjet printer. Histopathological results show a dramatic increase in the average microvasculature formation for mice that received the printed constructs within the implant area when compared to the manual and control implants, indicating inkjet bioprinting technology can be effectively used for vascularization of engineered tissues

    Characterization of the recombination activities of the Entamoeba histolytica Rad51 recombinase

    No full text
    The protozoan parasite responsible for human amoebiasis is Entamoeba histolytica. An important facet of the life cycle of E. histolytica involves the conversion of the mature trophozoite to a cyst. This transition is thought to involve homologous recombination (HR), which is dependent upon the Rad51 recombinase. Here, a biochemical characterization of highly purified ehRad51 protein is presented. The ehRad51 protein preferentially binds ssDNA, forms a presynaptic filament and possesses ATP hydrolysis activity that is stimulated by the presence of DNA. Evidence is provided that ehRad51 catalyzes robust DNA strand exchange over at least 5.4 kilobase pairs. Although the homologous DNA pairing activity of ehRad51 is weak, it is strongly enhanced by the presence of two HR accessory cofactors, calcium and Hop2-Mnd1. The biochemical system described herein was used to demonstrate the potential for targeting ehRad51 with two small molecule inhibitors of human RAD51. We show that 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS) inhibited ehRad51 by interfering with DNA binding and attenuated encystation in Entamoeba invadens, while B02 had no effect on ehRad51 strand exchange activity. These results provide insight into the underlying mechanism of homology-directed DNA repair in E. histolytica

    Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes

    No full text
    BACKGROUND: Currently available semiautomated insulin-delivery systems require individualized insulin regimens for the initialization of therapy and meal doses based on carbohydrate counting for routine operation. In contrast, the bionic pancreas is initialized only on the basis of body weight, makes all dose decisions and delivers insulin autonomously, and uses meal announcements without carbohydrate counting. METHODS: In this 13-week, multicenter, randomized trial, we randomly assigned in a 2:1 ratio persons at least 6 years of age with type 1 diabetes either to receive bionic pancreas treatment with insulin aspart or insulin lispro or to receive standard care (defined as any insulin-delivery method with unblinded, real-time continuous glucose monitoring). The primary outcome was the glycated hemoglobin level at 13 weeks. The key secondary outcome was the percentage of time that the glucose level as assessed by continuous glucose monitoring was below 54 mg per deciliter; the prespecified noninferiority limit for this outcome was 1 percentage point. Safety was also assessed. RESULTS: A total of 219 participants 6 to 79 years of age were assigned to the bionic-pancreas group, and 107 to the standard-care group. The glycated hemoglobin level decreased from 7.9% to 7.3% in the bionic-pancreas group and did not change (was at 7.7% at both time points) in the standard-care group (mean adjusted difference at 13 weeks, -0.5 percentage points; 95% confidence interval [CI], -0.6 to -0.3; P\u3c0.001). The percentage of time that the glucose level as assessed by continuous glucose monitoring was below 54 mg per deciliter did not differ significantly between the two groups (13-week adjusted difference, 0.0 percentage points; 95% CI, -0.1 to 0.04; P\u3c0.001 for noninferiority). The rate of severe hypoglycemia was 17.7 events per 100 participant-years in the bionic-pancreas group and 10.8 events per 100 participant-years in the standard-care group (P = 0.39). No episodes of diabetic ketoacidosis occurred in either group. CONCLUSIONS: In this 13-week, randomized trial involving adults and children with type 1 diabetes, use of a bionic pancreas was associated with a greater reduction than standard care in the glycated hemoglobin level. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; ClinicalTrials.gov number, NCT04200313.)

    Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review

    No full text
    corecore